Cat. No.: X24-09-YM075
HSP inhibitor, IPI-504, Purity ≥98%
Synonym: 857402-63-2; IPI504; Retaspimycin hydrochloride; Retaspimycin HCl; [(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13,20,22-Trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3-oxo-19-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18(22),19-hexaen-9-yl] carbamate; hydrochloride; HSP inhibitor
- CAS Number: 857402-63-2
- Compound CID: 11685945
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Properties
Description
IPI-504 is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting HSP. The molecular weight of the compound is 624.2, and its molecular formula is C31H46ClN3O8. It targets the GRP94 and HSP90.
Molecular Formula
C31H46ClN3O8
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
IPI-504 can be studied extensively for its potential therapeutic applications in the treatment of cancers by targeting and destabilizing oncogenic proteins.
Related Products
- HSP inhibitor, KOS953, Purity ≥98%
- HSP inhibitor, 17-DMAG HCl, Purity ≥98%
- HSP inhibitor, BIIB021, Purity ≥98%
- HSP inhibitor, Elesclomol, Purity ≥98%
- HSP inhibitor, AUY922, Purity ≥98%
- HSP inhibitor, NVP-BEP800, Purity ≥98%
